- Home
- RNXT vs RMTI Comparison
RNXT vs RMTI Comparison
Compare RNXT & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- RMTI
- Stock Information
- Founded
- RNXT 2012
- RMTI 1994
- Country
- RNXT United States
- RMTI United States
- Employees
- RNXT N/A
- RMTI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- RNXT Health Care
- RMTI Health Care
- Exchange
- RNXT Nasdaq
- RMTI Nasdaq
- Market Cap
- RNXT 37.6M
- RMTI 34.9M
- IPO Year
- RNXT 2021
- RMTI 1998
- Fundamental
- Price
- RNXT $1.06
- RMTI $1.12
- Analyst Decision
- RNXT Strong Buy
- RMTI Strong Buy
- Analyst Count
- RNXT 2
- RMTI 2
- Target Price
- RNXT $7.00
- RMTI $4.00
- AVG Volume (30 Days)
- RNXT 116.6K
- RMTI 182.2K
- Earning Date
- RNXT 05-15-2025
- RMTI 05-12-2025
- Dividend Yield
- RNXT N/A
- RMTI N/A
- EPS Growth
- RNXT N/A
- RMTI N/A
- EPS
- RNXT N/A
- RMTI N/A
- Revenue
- RNXT $43,000.00
- RMTI $101,489,000.00
- Revenue This Year
- RNXT $4,755.81
- RMTI N/A
- Revenue Next Year
- RNXT $187.93
- RMTI $10.42
- P/E Ratio
- RNXT N/A
- RMTI N/A
- Revenue Growth
- RNXT N/A
- RMTI 21.38
- 52 Week Low
- RNXT $0.75
- RMTI $0.86
- 52 Week High
- RNXT $1.69
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- RNXT 60.35
- RMTI 46.38
- Support Level
- RNXT $1.02
- RMTI $1.08
- Resistance Level
- RNXT $1.09
- RMTI $1.21
- Average True Range (ATR)
- RNXT 0.05
- RMTI 0.08
- MACD
- RNXT 0.01
- RMTI 0.02
- Stochastic Oscillator
- RNXT 80.00
- RMTI 36.67
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.